ClearSign Technologies Corp (CLIR): Nasdaq/NYSE listing notice — ClearSign receives Nasdaq bid price deficiency notice; reports record FY2024 revenue of $3.6M

ClearSign Technologies Corp

Nasdaq notified CLIR on April 1 that bid price below $1 for 30 consecutive business days; 180-day cure period until Sep 29, 2025.
Full year 2024 revenue $3.6M, up from $2.4M in 2023; cash ~$14M as of Dec 31, 2024.
Launched co-branded Zeeco CS5 burner line featuring ClearSign Core technology for low NOx and hydrogen.
Received follow-on purchase order for 26 burners at a Texas petrochemical facility.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ClearSign Technologies Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 1, 2025, ClearSign Technologies Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days beginning on February 18, 2025, and ending on March 31, 2025, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provide

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ClearSign Technologies Corp filing history →

Source: SEC EDGAR

accession 0001104659-25-031996

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.